In a report released today, Bruce Jackson from Benchmark Co. reiterated a Buy rating on Cardio Diagnostics Holdings (CDIO – Research Report), with a price target of $8.00. The company’s shares opened today at $1.40.
Jackson covers the Healthcare sector, focusing on stocks such as Humacyte, Cardio Diagnostics Holdings, and Seelos Therapeutics. According to TipRanks, Jackson has an average return of -5.9% and a 37.16% success rate on recommended stocks.
Cardio Diagnostics Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $8.00.
See the top stocks recommended by analysts >>
Based on Cardio Diagnostics Holdings’ latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $1.03 million. In comparison, last year the company had a GAAP net loss of $222.66 thousand
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Mana Capital Acquisition Corp is a blank check company.
